IOVANCE BIOTHERAPEUTICS, INC. Deferred State and Local Income Tax Expense (Benefit)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Deferred State and Local Income Tax Expense (Benefit) of -$760.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2021-02-25
- IOVANCE BIOTHERAPEUTICS, INC. deferred state and local income tax expense (benefit) for fiscal 2020 was -$760.00K.
- IOVANCE BIOTHERAPEUTICS, INC. deferred state and local income tax expense (benefit) for fiscal 2019 was -$3.56M.
- IOVANCE BIOTHERAPEUTICS, INC. deferred state and local income tax expense (benefit) for fiscal 2018 was -$2.02M, a 313.98% decline from fiscal 2017.
- IOVANCE BIOTHERAPEUTICS, INC. deferred state and local income tax expense (benefit) for fiscal 2017 was $944.00K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2020-12-31 | -$760.00K 10-K · filed 2021-02-25 |
| 2019-12-31 | -$3.56M 10-K · filed 2021-02-25 |
| 2018-12-31 | -$2.02M 10-K · filed 2021-02-25 |
| 2017-12-31 | $944.00K 10-K · filed 2020-02-25 |
| 2016-12-31 | -$3.01M 10-K · filed 2019-02-28 |
| 2015-12-31 | -$1.89M 10-K · filed 2018-03-12 |
| 2014-12-31 | -$1.16M 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |